| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/14/2002 | WO2002012279A2 Schizophrenia related gene and protein |
| 02/14/2002 | WO2002012274A2 Iapl-3 a protein inhibitor of apoptosis proteins |
| 02/14/2002 | WO2002012262A1 IDENTIFICATION OF cDNAs ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA |
| 02/14/2002 | WO2002005844A8 Protein complex serving as a vehicle for orally administerable medicaments |
| 02/14/2002 | WO2001098471A8 Human phosphodiesterases |
| 02/14/2002 | WO2001073082A3 Methods and cells for expression of recombinant protein products |
| 02/14/2002 | WO2001073080A3 Recombinant iron uptake proteins |
| 02/14/2002 | WO2001073018A3 Human tap-like protein (transporter associated in antigen processing/presentation) |
| 02/14/2002 | WO2001072838A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 02/14/2002 | WO2001064874A3 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/14/2002 | WO2001059120A3 Il-17 like molecules and uses thereof |
| 02/14/2002 | WO2001058951A3 Water-soluble ligand-binding proteins of ligand-gated ion channels, crystals thereof and their use for screening ligands of ligand-gated ion channels |
| 02/14/2002 | WO2001058921A3 Methods and compositions for generating angiostatin |
| 02/14/2002 | WO2001058915A3 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 02/14/2002 | WO2001057210A3 Use of dendroaspin as a vehicle for non-dendroaspin domains |
| 02/14/2002 | WO2001042288A3 G-protein coupled receptors |
| 02/14/2002 | WO2001036589A3 Human ex vivo immune system |
| 02/14/2002 | WO2001032906A3 Oligomers and oligomeric segments of alpha-hydroxy carboxylic acids and alpha-amino acids |
| 02/14/2002 | WO2001014418A3 p193 PROTEINS AND NUCLEIC ACIDS, AND USES THEREOF |
| 02/14/2002 | WO2000068258A3 Compounds exhibiting an antibiotic activity |
| 02/14/2002 | WO2000066143A9 Secreted proteins of mycobacterium tuberculosis and their use as vaccines and diagnostic reagents |
| 02/14/2002 | WO2000065062A3 Genome sequence and polypeptides of pyrococcus abissy, fragment and uses thereof |
| 02/14/2002 | WO2000044908A9 Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins |
| 02/14/2002 | WO2000009552A9 Secreted proteins and polynucleotides encoding them |
| 02/14/2002 | US20020019520 CBFBGA09: a human SL15 homolog |
| 02/14/2002 | US20020019342 In vitro modification of glycosylation patterns of recombinant glycopeptides |
| 02/14/2002 | US20020019046 Generating preferential aggregations; prepare suspension of stem cells, plate on solid surface, harvest aggregations |
| 02/14/2002 | US20020019029 Protein; for use in the treatment of cancer, cardiovascular disorders and nervous system disorders |
| 02/14/2002 | US20020019028 Peptide; for use in the treatment of defects associated with polypeptide transfer |
| 02/14/2002 | US20020018990 Reagents and methods useful for detecting diseases of the breast |
| 02/14/2002 | US20020018775 Complexing; separation; gene therapy |
| 02/14/2002 | US20020018750 Anticancer agents |
| 02/14/2002 | CA2418950A1 Soluble zcytor 11 cytokine receptors |
| 02/14/2002 | CA2418834A1 Iapl-3 a protein inhibitor of apoptosis proteins |
| 02/14/2002 | CA2418779A1 Schizophrenia related gene and protein |
| 02/14/2002 | CA2418445A1 Stress proteins and peptides and methods of use thereof |
| 02/14/2002 | CA2418386A1 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein |
| 02/14/2002 | CA2418144A1 Urocortin proteins and uses thereof |
| 02/14/2002 | CA2417888A1 Split-ubiquitin based reporter systems and methods of their use |
| 02/14/2002 | CA2417769A1 Drug metabolizing enzymes |
| 02/14/2002 | CA2417767A1 Peptides presented by cells |
| 02/14/2002 | CA2417707A1 Sid.rtm. nucleic acids and polypeptides selected from a pathogenic strain of hepatitis c virus and applications thereof |
| 02/14/2002 | CA2417676A1 Sequences for integrin alpha-8 |
| 02/14/2002 | CA2417587A1 Transporters and ion channels |
| 02/14/2002 | CA2417310A1 Iron regulating protein-2 (irp-2) as a diagnostic for neurodegenerative disease |
| 02/13/2002 | EP1179593A1 Process for producing recombinant insulin from novel fused protein |
| 02/13/2002 | EP1179592A1 Proteins nectin-3 |
| 02/13/2002 | EP1179591A1 Sodium ion-driven chloride/bicarbonate exchanger |
| 02/13/2002 | EP1179541A1 Compositions and methods for cancer treatment by selectively inhibiting VEGF |
| 02/13/2002 | EP1179540A1 Novel polypeptide |
| 02/13/2002 | EP1179539A1 Novel protein having hemolytic activity and gene encoding the protein |
| 02/13/2002 | EP1179350A2 Encapsulated cell system for implantation into the human CNS |
| 02/13/2002 | EP1179348A2 Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases |
| 02/13/2002 | EP1179070A2 Ers-genes, method of screening for chemical compounds capable of inducing ers in plants |
| 02/13/2002 | EP1179067A1 Neuroprotective properties of gdf-15, a novel member of the tgf-beta superfamily |
| 02/13/2002 | EP1179066A2 Extracellular signaling molecules |
| 02/13/2002 | EP1179065A2 Full-length molecules expressed in human tissues |
| 02/13/2002 | EP1179064A2 Secreted polypeptides and corresponding polynucleotides |
| 02/13/2002 | EP1179063A2 Genes expressed in hippocampus |
| 02/13/2002 | EP1179062A2 Nucleic acids and proteins with p53 activity and altered tetramerization domains |
| 02/13/2002 | EP1179061A1 Methods for treating tumors using antiangiogenic compounds |
| 02/13/2002 | EP1179055A1 Novel phytochelatin synthases and uses therefor |
| 02/13/2002 | EP1179022A2 Bufornin 1 as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins |
| 02/13/2002 | EP1179019A2 Immunogenic peptides derived from mage and the use thereof |
| 02/13/2002 | EP1179017A1 Expression of heparin-binding protein in recombinant mammalian cells |
| 02/13/2002 | EP1179015A1 Dna molecules encoding human clax proteins and their soluble fusion proteins |
| 02/13/2002 | EP1179014A1 Derivatives of the b or z domain from staphylococcal protein a (spa) interacting with at least one domain of human factor viii |
| 02/13/2002 | EP1179013A1 Protein scaffold and its use to multimerise monomeric polypeptides |
| 02/13/2002 | EP1179010A2 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
| 02/13/2002 | EP1179006A2 Novel g-protein modulator (gpm) proteins and nucleic acid molecules and uses therefor |
| 02/13/2002 | EP1179000A2 Secreted proteins and uses thereof |
| 02/13/2002 | EP1178829A1 Human monoclonal antibody |
| 02/13/2002 | EP1178828A1 Death domain containing receptor 4 |
| 02/13/2002 | EP0866876B1 Process for the preparation of recombinant proteins in e.coli by high cell density fermentation |
| 02/13/2002 | EP0812859B1 ANTIFACTOR Xa-TISSUE FACTOR PATHWAY INHIBITOR COMPLEX MONOCLONAL ANTIBODY AND USE OF THE SAME |
| 02/13/2002 | EP0693925B1 Production of a recombinant factor xa inhibitor of leech hirudo medicinalis |
| 02/13/2002 | EP0672756B1 Monoclonal antibody recognizing fk506-binding protein, method of assaying fk506-binding protein level, and kit thereof |
| 02/13/2002 | EP0630257B1 Thymus-derived, immune-enhancing agent for therapeutic use in immunocompromised hosts |
| 02/13/2002 | CN1335888A OPG fusion protein compositions and methods |
| 02/13/2002 | CN1335884A Interluckin 17-like receptor protein |
| 02/13/2002 | CN1335852A Novel depsipeptide compound |
| 02/13/2002 | CN1335405A Collagen preparing process |
| 02/13/2002 | CN1335404A Polypeptide preparing process |
| 02/12/2002 | US6346607 A protein that induces apoptosis or binds cytochrome c; diagnosis and therapy for multiple sclerosis, parkinson's and alzheimer's diseases, cardiovascular diseases, strokes, toxin induced liver disease, cancer, lupus and herpes virus |
| 02/12/2002 | US6346606 A protein; diagnosis and therapy for tumor diseases, central nervous system diseases, glioblastomas, and breast cancer |
| 02/12/2002 | US6346409 Tryptophenyl tRNA synthetase from Streptococcus pneumoniae |
| 02/12/2002 | US6346406 Elongation factor-2 kinase (EF-2 kinase), and methods of use therefor |
| 02/12/2002 | US6346392 Amino acid sequence from streptococcus; drug screening of bactericides and bacteriostats |
| 02/12/2002 | US6346388 Method of identifying agonist and antagonists for tumor necrosis related receptors TR1 and TR2 |
| 02/12/2002 | US6346381 Determination whether nucleotides from individual have one or more pg1-related biallelic markers or mutants; medical diagnosis |
| 02/12/2002 | US6346375 NANBV diagnostics and vaccines |
| 02/12/2002 | US6346248 Methods of treating autoimmune diseases with a CD86-specific immunotoxin |
| 02/12/2002 | US6346246 Antibodies that bind human haemopoietic maturation factor |
| 02/12/2002 | CA2222810C Process for recovering water-insoluble compounds from a fermentation broth |
| 02/12/2002 | CA2068204C Latency associated peptides and uses therefor |
| 02/12/2002 | CA2066491C Human neurokinin-1 receptor |
| 02/12/2002 | CA1341339C Arg-serpin human plasminogen activator inhibitor designated pai-2 |
| 02/09/2002 | CA2354726A1 Sodium ion-driven chloride/bi-carbonate exchanger |
| 02/07/2002 | WO2002010430A2 Detecting anti-viral drug candidates and resistance |
| 02/07/2002 | WO2002010414A2 Expression of biologically active polypeptides in duckweed |